| Embassy Of Hearthside | |
| 450 Waupelani Drive, State College, Pennsylvania 16801 | |
| (814) 237-0630 | |
| Name | Embassy Of Hearthside |
|---|---|
| Location | 450 Waupelani Drive, State College, Pennsylvania |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 157 |
| Occupancy Rate | 71.27% |
| Medicare ID (CCN) | 395868 |
| Legal Business Name | Embassy Hearthside, Llc |
| Ownership Type | For Profit - Partnership |
| NPI Number | 1174586002 |
| Organization Name | UNIVERSITY PARK NURSING, LP |
| Doing Business As | THE HEARTHSIDE, A NURSING & REHABILITATION CENTER |
| Address | 450 Waupelani Drive, State College, PA 16801 |
| Phone Number | 814-237-0630 |
News Archive
Despite widespread belief among cancer patients and health care professionals that acupuncture helps relieve nausea caused by cancer treatment, new research in radiotherapy has found it does not.
A national study of 20,000 patients conducted by RCSI University of Medicine and Health Sciences and the HSE Health Protection Surveillance Centre (HPSC) has identified the underlying conditions that are associated with more severe outcomes from COVID-19 in an Irish setting.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has advanced to the RNAi therapeutic collaboration stage of its landmark alliance with Roche formed in 2007.
Researchers at the National Institute of Allergy and Infectious Diseases (NIAID)'s Vaccine Research Center (VRC) and the University of Washington School of Medicine's Institute for Protein Design (IPD) developed a universal flu vaccine candidate using small particles (nanoparticles), which can induce a long-lasting immune response.
› Verified 1 days ago
| NPI Number | 1184958308 |
| Organization Name | THE HEARTHSIDE SNF LLC |
| Doing Business As | THE HEARTHSIDE REHABILITATION AND NURSING CENTER |
| Address | 450 Waupelani Dr, State College, PA 16801 |
| Phone Number | 814-237-0630 |
News Archive
Despite widespread belief among cancer patients and health care professionals that acupuncture helps relieve nausea caused by cancer treatment, new research in radiotherapy has found it does not.
A national study of 20,000 patients conducted by RCSI University of Medicine and Health Sciences and the HSE Health Protection Surveillance Centre (HPSC) has identified the underlying conditions that are associated with more severe outcomes from COVID-19 in an Irish setting.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has advanced to the RNAi therapeutic collaboration stage of its landmark alliance with Roche formed in 2007.
Researchers at the National Institute of Allergy and Infectious Diseases (NIAID)'s Vaccine Research Center (VRC) and the University of Washington School of Medicine's Institute for Protein Design (IPD) developed a universal flu vaccine candidate using small particles (nanoparticles), which can induce a long-lasting immune response.
› Verified 1 days ago
| NPI Number | 1467069005 |
| Organization Name | EMBASSY HEARTHSIDE, LLC |
| Address | 450 Waupelani Dr, State College, PA 16801 |
| Phone Number | 814-237-0630 |
News Archive
Despite widespread belief among cancer patients and health care professionals that acupuncture helps relieve nausea caused by cancer treatment, new research in radiotherapy has found it does not.
A national study of 20,000 patients conducted by RCSI University of Medicine and Health Sciences and the HSE Health Protection Surveillance Centre (HPSC) has identified the underlying conditions that are associated with more severe outcomes from COVID-19 in an Irish setting.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has advanced to the RNAi therapeutic collaboration stage of its landmark alliance with Roche formed in 2007.
Researchers at the National Institute of Allergy and Infectious Diseases (NIAID)'s Vaccine Research Center (VRC) and the University of Washington School of Medicine's Institute for Protein Design (IPD) developed a universal flu vaccine candidate using small particles (nanoparticles), which can induce a long-lasting immune response.
› Verified 1 days ago
| NPI Number | 1972046506 |
| Organization Name | HEARTHSIDE REHAB CENTER LLC |
| Address | 450 Waupelani Dr, State College, PA 16801 |
| Phone Number | 814-237-0630 |
News Archive
Despite widespread belief among cancer patients and health care professionals that acupuncture helps relieve nausea caused by cancer treatment, new research in radiotherapy has found it does not.
A national study of 20,000 patients conducted by RCSI University of Medicine and Health Sciences and the HSE Health Protection Surveillance Centre (HPSC) has identified the underlying conditions that are associated with more severe outcomes from COVID-19 in an Irish setting.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has advanced to the RNAi therapeutic collaboration stage of its landmark alliance with Roche formed in 2007.
Researchers at the National Institute of Allergy and Infectious Diseases (NIAID)'s Vaccine Research Center (VRC) and the University of Washington School of Medicine's Institute for Protein Design (IPD) developed a universal flu vaccine candidate using small particles (nanoparticles), which can induce a long-lasting immune response.
› Verified 1 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Despite widespread belief among cancer patients and health care professionals that acupuncture helps relieve nausea caused by cancer treatment, new research in radiotherapy has found it does not.
A national study of 20,000 patients conducted by RCSI University of Medicine and Health Sciences and the HSE Health Protection Surveillance Centre (HPSC) has identified the underlying conditions that are associated with more severe outcomes from COVID-19 in an Irish setting.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has advanced to the RNAi therapeutic collaboration stage of its landmark alliance with Roche formed in 2007.
Researchers at the National Institute of Allergy and Infectious Diseases (NIAID)'s Vaccine Research Center (VRC) and the University of Washington School of Medicine's Institute for Protein Design (IPD) developed a universal flu vaccine candidate using small particles (nanoparticles), which can induce a long-lasting immune response.
› Verified 1 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 1 |
| Total Amount of Fines in Dollars | $13078 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 1 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 20.95 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 8.88 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 44.24 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 1.91 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 3.76 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 1.57 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 4.68 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 94.26 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 28.01 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 76.69 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 1.6 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 31.27 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 55.92 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 7.83 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 96.79 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 71.78 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 75.31 | 82.93 |
News Archive
Despite widespread belief among cancer patients and health care professionals that acupuncture helps relieve nausea caused by cancer treatment, new research in radiotherapy has found it does not.
A national study of 20,000 patients conducted by RCSI University of Medicine and Health Sciences and the HSE Health Protection Surveillance Centre (HPSC) has identified the underlying conditions that are associated with more severe outcomes from COVID-19 in an Irish setting.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has advanced to the RNAi therapeutic collaboration stage of its landmark alliance with Roche formed in 2007.
Researchers at the National Institute of Allergy and Infectious Diseases (NIAID)'s Vaccine Research Center (VRC) and the University of Washington School of Medicine's Institute for Protein Design (IPD) developed a universal flu vaccine candidate using small particles (nanoparticles), which can induce a long-lasting immune response.
› Verified 1 days ago
Juniper Village At Brookline-rehabilitation And Sk Location: 1950 Cliffside Drive, State College, Pennsylvania 16801 Phone: (814) 238-3139 | |
Foxdale Village Location: 500 E. Marylyn Avenue, State College, Pennsylvania 16801 Phone: (814) 238-3322 | |
Embassy Of Hearthside Location: 450 Waupelani Drive, State College, Pennsylvania 16801 Phone: (814) 237-0630 | |
Village At Penn State, The Location: 260 Lion's Hill Road, State College, Pennsylvania 16803 Phone: (814) 238-1949 |